PLEKHA7 and lung adenocarcinoma: This is the first case presenting a rare concomitant ALK double-fusion, namely PLEKHA7-ALK and INPP5D-ALK, in a patient with lung adenocarcinoma, who exhibited favorable sensitivity to alectinib.